premium content
You can all guess what the latest Rightmove survey is saying
It is the last big week of the year for macroeconomic watchers, with the Bank of England, the Federal Reserve and the European Central Bank all set to raise interest rates again. How…predictable. What will interest me is how worried they are about 2023. I see the chancellor has been banging on about a UK economy which is “likely to get worse before it gets better” and “I don't know whether inflation has peaked or not”. Maybe Santa will help out 11 Downing Street? Meanwhile, let’s have a quick focus on what Rightmove (RMV) said today.- By Chris Bailey |
- 12 December 2022, 10:27 |
Big Pharmas Still Enjoy Strong Tailwinds and this Jumping Jumbo Seems Better Placed than Most
Hello Share Twiddlers. I’ve been saying that the wisest policy at the mo seems to be to avoid buying shares. As usual, there are exceptions. For example, I fail to see how big pharmas can go into reverse. That’s because of three factors. A growing ageing population, new viruses and scientific strides in medical treatments.- By Malcolm Stacey |
- 12 December 2022, 08:17 |
premium content
Tom Winnifrith Bearcast: beware what a delirious Tom says, is this the end of Zak Mir at Lift?
First things first. We now need just £240 to wrap up the Woodlarks Christmas appeal. Please give a tenner HERE so we can do that on Monday. Thank you in advance. Second I am a bit delirious and explain why. Finally, is this the end of Zak Mir at the Lift Global Ventures (LFT) swizzle?- By Tom Winnifrith |
- 11 December 2022, 20:04 |
premium content
Forget a flash (Christmas) lunch and go active!
The really good news is that December 2022 will be my tenth lack of a Christmas lunch with any institutional brokers. Thank goodness for that, as they have become even more pointless recently…- By Chris Bailey of Financial Orbit |
- 11 December 2022, 19:25 |
premium content
TruSpine – The Aquis Comedy Shit-Show Heads For Disaster
I have been keeping an eye on Aquis lobster-pot listed Truspine (TSP) for almost two years, ever since it announced on Christmas Eve 2020 that its application for FDA clearance for its Cervi-Lok product would not be in by the end of the year, as promised at its IPO the previous August. The company has been remarkably silent since announcing that its financial position remained weak on 31st October this year. Hmm…….- By Nigel Somerville |
- 11 December 2022, 14:59 |
premium content
The annual Woodlarks Christmas Grotto appeal from Tom Winnifrith, just £20 shy of target! - can you get us over the line?
I know times are tough. But I am sure that if you are reading this you can afford a tenner or a fiver. And I ask that you hand that over to the amazing folks at Woodlarks as it does its first face to face Santa grottos for 200 kids whose, often short, lives are not like those we enjoy.- By Tom Winnifrith |
- 11 December 2022, 07:19 |
premium content
Sunday Long Reads: MBS’s place coup, The Saudi oil strategy, Who gets to be mentally ill, LSD’s comeback, Editing DNA
Here are five long reads that have nothing to do with shares.. Put the kettle on, find a comfy chair. You have the time, don't you?
- By Darren Atwater |
- 11 December 2022, 06:45 |
premium content
The ShareProphets Sunday Pub Quiz #171
It's time for thw ShareProphets Sunday Pub Quiz. Put the kettle on, put your score in the comments, and No Googling!
- By Darren Atwater |
- 11 December 2022, 06:44 |
premium content
Visual Aid: The world’s money and markets illustrated
This latest image from Visual Capitalist comparing the world's money and markets is fascinating. I'd suggest a pot of tea for this story alone.- By Darren Atwater |
- 11 December 2022, 06:44 |
Notes from Underground – Most read articles for the week ending 10 Dec 2022
The most-read non-quiz non-Tom article this week is from Gary Newman with Horizonte Minerals is on the verge of debt drawdown to complete the Araguaia mine – still a Buying opportunity? at No 9 or No 15 including Bearcasts.
- By Darren Atwater |
- 11 December 2022, 06:43 |
premium content
Tom Winnifrith Bearcast: why Gary Newman is so wrong on Coro
But we believe in free speech here so Gary is entitled to his opinion. But I explain why, in my view, Coro Energy (CORO) is a bargepole stock. The good news today is that we have now raised 84% of our Woodlarks Christmas Grotto appeal target. Please shut me up and donate a tenner (or more) to raise that last £443 HERE- By Tom Winnifrith |
- 10 December 2022, 16:55 |
premium content
When you bank is trouble you are really screwed – yes its Argo Blockchain again
We still have no statement from Argo Blockchain (ARB) regarding its share suspension on Friday and a possible Chapter 11 filing. But if you think Argo has problems ( it does it is bust) have a look at its main bank, NYDIG, the company’s primary secured lender.- By Tom Winnifrith |
- 10 December 2022, 16:22 |
premium content
SHOCKING EXPOSE: Evrima – this is taking the piss! Free money for the boss!
I have highlighted before that Aquis listed Evrima (EVA) is worthless POS, with shocking corporate governance. Now there is an AGM planned for 28 December and CEO Burns Tennent Bohi really is taking the piss on a gargantuan scale. Let me explain:- By Tom Winnifrith |
- 10 December 2022, 15:38 |
premium content
The View From The Montana Log-Cabin As Gold Again Challenges $1800
Gold finished the week at $1798 – exactly where it was last week. However, story in between times was that it dropped to around $1770 before pushing back up towards the $1800 mark. Jordan Roy-Byrne, of TheDailyGold.com seems now convinced the bottom is in on Gold’s correction since the heady days 16 months ago at the height of Covid. Now all we wait for is for precious metals to decouple from the general stock market as recession and debt worries bite.- By Nigel Somerville |
- 10 December 2022, 14:55 |
Flowtech Fluidpower – again a Buy?
Fluid power products business Flowtech Fluidpower (FLO) is a company we have successfully covered on this website before – banking a less than six months 39.5% offer to bid gain last year at a 117.5p bid price, though also noting then that on continuing strong trading recovery delivery there is likely some further upside. The shares went on to reach 150p and this year’s half-year numbers showed further positive trading recovery… but the shares are currently available at a 109.5p offer price. We therefore now ride again, targeting a return to 140p+ as trading delivery is further proven and market sentiment improves from here.- By HotStockRockets |
- 10 December 2022, 08:01 |
Tharisa – full-year results, valuation remains highly attractive
Tharisa (THS) has announced results for its year ended 30th September 2022 and that “the long-life Karo platinum project, when added to the 60+year LOM of the Tharisa PGM and chrome operations in South Africa, sets the foundation for Tharisa's growth”.- By HotStockRockets |
- 10 December 2022, 08:00 |
Strike a Light! Shares could Suffer Even More as Blighty Becomes a Third World Country.
Hello Share Managers. There’s less than a fortnight to your cool yule. But there’s still time for a Santa rally. Except that there won’t be one this year. I can hardly believe I’m saying this but there isn't a bullish thought in my old body at present. Here’s why.- By Malcolm Stacey |
- 10 December 2022, 07:59 |
premium content
Tom Winnifrith Bearcast: More Albanian problems and more Kefi shareholders on my case - I communicate with ’arry Adams
I explain my latest Albanian problem on day three of the harvest. The it is onto Kefi Gold & Copper (KEFI), Yourgene (YGEN), Kibo (KIBO), Procook (PROC) and Argo Blockchain (ARB). There is a bit of swearing for Catriona and Matthew's Dog since Matthew and C's Dad have both donated to the Woodlarks Christmas appeal. Thanks to them and you all we are now at 64% of target. If you are yet to donate, please shut me up and donate HERE.- By Tom Winnifrith |
- 9 December 2022, 16:22 |
IXICO – “contract win”. Is it?, and what about the contract loss and financial outlook?
Medical analytics company IXICO plc (IXI) has announced that it “has been selected by a leading global pharmaceutical company, and new client, to provide MRI imaging services for an early phase clinical trial”. So what’s the detail, with the shares currently up approaching 4% at 26.5p in response?- By Steve Moore |
- 9 December 2022, 15:57 |
premium content
Procook – told y’all another warning, an extra ouzo for the Sheriff of AIM tonight!
I explicitly warned you to dodge the Procook (PROC) IPO at 145p on November12 last year. Since then there have been a catalogue of profits warnings and today, just 40 days after the last trading statement there is another savage warning. It will not be the last and the shares, at just 28p, are for morons and financial masochists only.- By Tom Winnifrith |
- 9 December 2022, 15:38 |